Study of ACI-19764 for healthy people and those with heart risks
Part of Hormones & metabolism clinical trials.
This trial tests an experimental drug called ACI-19764 to see how safe it is, how the body handles it, and how it affects the immune system. It's for healthy adults and for adults with heart-related risk factors like obesity or type 2 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old (healthy) or up to 75 years old if you have heart risk factors.
- If you are healthy, your body mass index (BMI) must be between 18 and 29.9.
- If you have heart risk factors, you may have obesity (BMI 30-42) or well-controlled type 2 diabetes.
- If you have heart risk factors, you need a blood test showing a certain level of inflammation (CRP between 3 and 10 mg/L).
- You must be a non-smoker (no nicotine for at least 3 months before the study).
- You must be willing to follow strict birth control rules if you are fertile.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests a new investigational medication in three groups: healthy adults with normal weight, adults who are overweight or obese, and men with type 1 diabetes who are also overweight. The research aims to understand how safe the medication is and how the body processes it.
This study tests a new medicine (NNC6022-0004) in healthy volunteers and people with obesity to check its safety. If you qualify, you may help see if this drug is safe for future use.
This study tests a new oral medication called ACCG-2671 to see how safe it is and how your body handles it. It's an early-stage trial, so the main focus is on safety and tolerability. The study has different parts: one for people with normal weight and one for people with higher weight who are already taking a GLP-1 injection for weight loss.
This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
This study tests a new medicine (NNC9733-0001) to see how it works in healthy people and in people with type 2 diabetes. It helps researchers understand safety and how the body processes the drug.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.